| |
|
|
|
Poseida Therapeutics Inc  
|
|
8.17 -0.08 (-0.01%) |
09-16 16:00 |
|
Open: |
8.27 |
Pre close: |
8.25 |
Target:
|
11.58
|
|
High: |
8.35 |
Low: |
8.065 |
Resistance:
|
9.92
11.10
|
|
Volume: |
90,691 |
Market Cap: |
509M |
Support:
|
8.00
6.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.23
 |
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
8.79 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
8.83 |
Stochastic Oscillator |
%K(14,3):
|
5.81 |
|
MA(250): |
9.54 |
%D(3): |
7.28 |
|
Average Volume(K) |
3-Month: |
748475
|
52-Week |
High:
|
13.98 |
|
10-Days: |
642955 |
Low: |
7.81 |
|
RSI |
RSI(14):
|
43.19 |
Change(%): |
-15.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-100.0 |
Shares Out. (M) |
62.15 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-36.0 |
Shares Float (M) |
32.54 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
49.95 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1680 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-2.369 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-129.79 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-82.17 |
P/CF |
-3.91 |
|
|
|
|
|
|
